Connect
MJA
MJA

Poppy seed tea dependence requiring depot buprenorphine treatment

Shalini Arunogiri, Rowan Dowling, Vicky Phan, Michelle Sharkey, Temika Mu and Dan I Lubman
Med J Aust || doi: 10.5694/mja2.51334
Published online: 22 November 2021

 

  • Shalini Arunogiri1
  • Rowan Dowling1,2
  • Vicky Phan1
  • Michelle Sharkey1
  • Temika Mu1
  • Dan I Lubman1

  • 1 Turning Point, Eastern Health and Monash University, Melbourne, VIC
  • 2 La Trobe University, Melbourne, VIC



Acknowledgements: 

We acknowledge the contributions of Keri Alexander and Stephanie Dias to the treatment provided.

Competing interests:

Shalini Arunogiri has received speaker honoraria from Gilead, Janssen‐Cilag and Camurus. Dan Lubman has provided consultancy advice to Lundbeck and Indivior, has received travel support and speaker honoraria from AstraZeneca, Janssen, Lundbeck, Shire and Servier, and has been an investigator on an untied education grant from Sequirus. All of the above payments and services are unrelated to the present article.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.